1. Market Research
  2. > Pathology
About 100 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Nuclear Medicine Market - Opportunities and Forecast (2013-2023)

  • $ 2400
  • January 2019
  • 244 pages

lymphoma where as samarium-##-EDTMP, and strontium-##-chloride for palliation of bone metastases.

  • Lymphoma
  • Neurological Disorder
  • Pathology
  • World
  • Cardinal Health, Inc.

Global Medical Cannabis Market - Opportunities and Forecast (2014-2024)

  • $ 2400
  • March 2019
  • 290 pages

Figure ##: US New Cases of Cancer, By Type, 2018 (In %) ##. ##% ##. ##% ##. ##% ##. ##% ##. ##% ##. ##% ##. ##% ##. ##% ##. ##% Digestive System Respiratory System Skin Genital System Breast Urinary System Endocrine System Lymphoma Others Source: American Society of Cancer US MEDICAL CANNABIS MARKET, BY

  • Marijuana
  • Neurological Disorder
  • Recreational Activity
  • World
  • Market Size

Global Central Nervous System Therapeutic Market - Opportunities and Forecast (2014-2024)

  • $ 2200
  • March 2019
  • 214 pages

There are several types of brain tumor depending upon the kind of cell which is infected such as gilomas, epidermoid, lymphoma, meningioma etc.

  • Health Services
  • Lymphoma
  • Neurological Disorder
  • Neurology
  • World

Medical Marijuana - Thematic Research

  • $ 7995
  • November 2019
  • 186 pages

Medical Marijuana: Innovative Pipeline Shows Promise For Treating More Than ## Indications © GlobalData 2019 This product is licensed and is not to be photocopied.

  • Lymphoma
  • Marijuana
  • Neurological Disorder
  • Neurology
  • Medical Marijuana, Inc.

Global Genetic Disorders Drugs Market to 2023 - A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease

  • $ 4995
  • December 2017
  • 160 pages

They also have an increased risk of Parkinson' s disease, and cancers such as myeloma, leukemia and lymphoma.

  • Clinical Trial
  • Genetic Disorder
  • Lymphoma
  • Neurological Disorder
  • Therapy

Global Myasthenia Gravis Drugs Market 2017-2021

  • $ 2500
  • January 2017
  • 73 pages

2017-2021 TECHNAVIO.

  • Neurological Disorder
  • Alexion Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Flamel Technologies S.A.
  • Pfizer Inc.

National Institute of Neurological Disorders and Stroke - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • September 2018
  • 68 pages

a postdoctoral fellow in the Lieberman Lab, received The Leukemia & Lymphoma Society Career Development Fellow Award for $##, ## over three years to support a research project on the functions of an Epstein-Barr virus protein called EBNA## in regulating host gene expression.

  • Lymphoma
  • Mental Health
  • Neurological Disorder
  • Stroke
  • United States

Brainstorm Cell Therapeutics, Inc. (USA)

  • $ 1500
  • January 2016
  • 32 pages

Lymphoma by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others.............. ## Table ##: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Lymphoproliferative by Region Worldwide (2015) - Percentage Market Share Breakdown by Val

  • Lymphoma
  • Neurological Disorder
  • Stem Cell Transplant
  • Transplantation
  • Market Shares

Serine Protein Kinase ATM - Pipeline Review, H1 2020

  • $ 3500
  • January 2020
  • 35 pages

Lymphoma, Multiple Myeloma (Kahler Disease), Solid Tumor and Squamous Cell Carcinoma.

  • Lymphoma
  • Neurological Disorder
  • Therapy
  • Product Initiative
  • AstraZeneca PLC

Serine Protein Kinase ATM - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 35 pages

Lymphoma, Multiple Myeloma (Kahler Disease), Solid Tumor and Squamous Cell Carcinoma.

  • Lymphoma
  • Neurological Disorder
  • Therapy
  • Product Initiative
  • AstraZeneca PLC

Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H1 2020

  • $ 2000
  • March 2020
  • 147 pages

It is in Phase II/ III stage of development for diffuse B-cell lymphoma, follicular lymphoma, nodal marginal zone lymphoma, refractory mantle cell lymphoma and extranodal marginal zone lymphoma.

  • Lymphoma
  • Monoclonal Antibody
  • Neurological Disorder
  • Therapy
  • Alexion Pharmaceuticals, Inc.

Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H2 2019

  • $ 2000
  • November 2019
  • 146 pages

It is in Phase II/ III stage of development for diffuse B-cell lymphoma, follicular lymphoma, nodal marginal zone lymphoma, refractory mantle cell lymphoma and extranodal marginal zone lymphoma.

  • Lymphoma
  • Monoclonal Antibody
  • Neurological Disorder
  • Therapy
  • Alexion Pharmaceuticals, Inc.

Nuclear Factor Erythroid 2 Related Factor 2 - Pipeline Review, H1 2020

  • $ 3500
  • February 2020
  • 145 pages

lymphoma and other cancers.

  • Hospital
  • Lymphoma
  • Neurological Disorder
  • Pharmaceutical
  • Therapy

Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) - Pipeline Review, H2 2018

  • $ 3500
  • November 2018
  • 32 pages

Lymphoma, Multiple Myeloma (Kahler Disease), Solid Tumor and Squamous Cell Carcinoma.

  • Lymphoma
  • Neurological Disorder
  • World
  • Product Initiative
  • AstraZeneca PLC

Serine/Threonine Protein Kinase ATR (Ataxia Telangiectasia And Rad3 Related Protein or FRAP Related Protein 1 or ATR or EC 2.7.11.1) - Pipeline Review, H1 2018

  • $ 3500
  • June 2018
  • 44 pages

As of December 2013, it was in Phase I stage for prolymphocytic leukemia (PLL), hairy cell leukemia (HCL), indolent b-cell l lymphoma, Burkitt lymphoma, acute lymphocytic leukemia.

  • Lymphoma
  • Neurological Disorder
  • Therapy
  • World
  • Product Initiative

Myasthenia Gravis - Pipeline Review, H1 2020

  • $ 2000
  • January 2020
  • 207 pages

As of April 2006, the drug candidate was in Phase II stage of development as second line therapy for B-cell lymphomas including marginal zone B-cell lymphoma, nodal marginal zone B-cell lymphoma, extranodal marginal zone B-cell lymphoma, splenic marginal zone B-ce

  • Lymphoma
  • Neurological Disorder
  • Pharmaceutical
  • Therapy
  • Alexion Pharmaceuticals, Inc.

Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) - Pipeline Review, H1 2018

  • $ 3500
  • May 2018
  • 31 pages

Report covers products from therapy areas Oncology and Ophthalmology which include indications Head And Neck Cancer, Adenocarcinoma, Colorectal Cancer, Gastric Cancer, Glioblastoma Multiforme (GBM), Herpetic Keratitis, Human Papillomavirus (HPV) Associated Cancer, Lymphoma, Multiple Myeloma

  • Lymphoma
  • Neurological Disorder
  • World
  • Product Initiative
  • AstraZeneca PLC

U.S. Therapeutic Plasma Exchange Market by Indication, Procedures & Patients - Forecasts to 2021

  • $ 4950
  • July 2016
  • 91 pages

This condition is called lymphoplasmacytic lymphoma.

  • Autoimmune Disease
  • Infectious Disease
  • Lymphoma
  • Neurological Disorder
  • United States

Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2020

  • $ 2000
  • June 2020
  • 68 pages

It is in Phase II stage for acute myelocytic leukemia, chronic myelocytic leukemia, myelodysplastic syndrome, burkitt lymphoma, Hodgkin lymphoma, Tcell lymphoma and mantle cell lymphoma.

  • Gene Therapy
  • Lymphoma
  • Medical Biotechnology
  • Neurological Disorder
  • Therapy

Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 91 pages

It is in Phase II stage for acute myelocytic leukemia, chronic myelocytic leukemia, myelodysplastic syndrome, burkitt lymphoma, Hodgkin lymphoma, Tcell lymphoma and mantle cell lymphoma.

  • Dementia
  • Lymphoma
  • Neurological Disorder
  • Therapy
  • POXEL SA
View report >

Asthma Statistics in the UK

  • January 2017
  • 15 pages

Cancer Chart ##. ## shows the most common cancers for this age group are lymphomas, including cancer of the lymph system, Hodgkin Disease and non-Hodgkin Lymphoma, followed by carcinomas (malignant tumours on the surface or lining of a body organ).

  • Asthma
  • Lymphoma
  • Neurological Disorder
  • United Kingdom
  • Diabetes UK

Global Therapy Market January 2018

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on